Previous 10 | Next 10 |
Better Therapeutics (BTTX) +12%. Insulet Corporation (PODD) +11% DexCom - Insulet buyout deal unlikely, Bank of America says. Cango (CANG) +10%. Roivant Sciences (ROIV) +10% gets FDA approval for plaque psoriasis therapy Vtama cream. Creative Medical Technology (CELZ) +9%....
The U.S. Food and Drug Administration (FDA) approved Vtama (tapinarof) cream, a topical treatment of plaque psoriasis in adults, developed by Dermavant Sciences, a unit of Roivant Sciences (NASDAQ:ROIV). The company said approval makes Vtama cream, an aryl hydroc...
- EFFICACY: In the pivotal Phase 3 clinical trial program, VTAMA cream met all primary and secondary endpoints and demonstrated highly statistically significant improvement versus vehicle in Physician Global Assessment (PGA) score with 36% of patients versus 6% in vehicle in PSOARING 1 an...
ARU-1801 reduced vaso-occlusive events and days in the hospital for patients with severe sickle cell disease MILLBURN, N.J. and BASEL, Switzerland, May 16, 2022 (GLOBE NEWSWIRE) -- Aruvant Sciences ("Aruvant"), a private company focused on developing gene therapies for rare d...
Dr. Srini Ramanathan has over 20 years of experience in drug development and joins Roivant from Horizon Therapeutics where he built scientific R&D capabilities and teams to advance the company’s preclinical and clinical portfolio In addition to internal pipeline programs, R...
VantAI will pair its induced proximity platform with BI’s deep early discovery experience to identify targeted protein degraders with enhanced properties for traditionally “undruggable” targets NEW YORK and INGELHEIM, Germany, April 20, 2022 (GLOBE NEWSWIRE) -- ...
NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- VantAI, an AI-first induced-proximity company, today announced it has entered into a multi-year collaboration agreement with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (‘Janssen’)....
Tapinarof demonstrated continued improvements for up to 52 weeks in efficacy outcomes, quality of life measures, and tolerability scores with no associated tachyphylaxis Tapinarof was well-tolerated in sensitive skin and intertriginous areas with majority of patients experiencing ...
NEW YORK, March 24, 2022 (GLOBE NEWSWIRE) -- Roivant Social Ventures, a nonprofit philanthropic social impact organization launched by Roivant Sciences, today announced a major collaboration with Sanford Burnham Prebys, San Diego’s prestigious medical discovery institute. The groundb...
Halvorsen's 13F portfolio value decreased from $36.04B to $34.49B this quarter. The number of positions increased from 96 to 107. Viking Global added Twilio, Workday, and Aon plc while dropping Fidelity National Information Services and Snowflake. The top three positions are Ginkg...
News, Short Squeeze, Breakout and More Instantly...
Roivant Sciences Ltd. Company Name:
ROIV Stock Symbol:
NASDAQ Market:
Roivant Sciences Ltd. Website:
2024-07-11 10:45:04 ET Rivian Automotive Inc (RIVN) RIVN is trading UP for the last 5 days, and it at trading at $16.74 with volume of 18,885,597 and a one day change of $0.37 (2.23%). Rivian Automotive Inc has a 52-week low of 12.15 and a 52-week high of $32.60. The business's 50-d...
2024-06-02 17:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BASEL, Switzerland and LONDON and NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2024, and provided a business update. Once-daily brepocitinib produced the best Treatment Failure...